In the late stage of infection, or (in our study) long after vaccination, YF-tetramer+CD8+ T-cells for instance have a heterogeneous expression of CD28 and have re-expressed CD45RA, as is seen in CMV-specific late stage effector cells. The gene discussed is CD8A; the disease is infection.